Related Experiment Videos
Enteral feeding and gut atrophy
1Department of Internal Medicine, Center for Human Nutrition, Washington University School of Medicine, St Louis, MO 63110, USA. dalpers@im.wustl.edu
Current Opinion in Clinical Nutrition and Metabolic Care
|October 24, 2002
Summary
Enteral nutrition may not prevent intestinal mucosal atrophy in humans as it does in animal models. Research suggests focusing on gene adaptation during fasting and malnutrition for future therapeutic strategies.
Area of Science:
- Gastroenterology
- Nutrition Science
- Cellular Biology
Background:
- Enteral feeding is hypothesized to prevent intestinal mucosal atrophy and bacterial translocation during fasting or malnutrition.
- Parenteral nutrition alone can lead to significant intestinal mucosal mass reduction in animal models, but human relevance is unclear.
Purpose of the Study:
- To review recent findings (last 2 years) on the dilemma of enteral versus parenteral nutrition regarding intestinal mucosal atrophy.
- To evaluate the evidence for enteral feeding's role in preventing mucosal atrophy in humans.
Main Methods:
- Review of scientific literature published within the last two years.
- Analysis of studies conducted in animal models (rats, pigs) and human subjects.
Main Results:
- Animal studies in rats and pigs confirm mucosal atrophy with fasting, with some hormonal and glutamine effects corroborated but lacking proper controls.
- In humans, significant mucosal atrophy is not consistently observed, with only modest decreases reported in catabolic states; enteral feeding has not shown evidence of reversal.
- Emerging evidence in both animals and humans points to specific gene adaptations occurring during fasting and malnutrition, irrespective of mucosal atrophy.
Conclusions:
- The emphasis on mucosal atrophy may overshadow simultaneous adaptive processes.
- Investigating gene adaptation during fasting and malnutrition holds promise for developing future therapeutic interventions.